FR2705032B1 - Composition comprising in combination an immunoglobulin and an antigen usable in therapy. - Google Patents

Composition comprising in combination an immunoglobulin and an antigen usable in therapy.

Info

Publication number
FR2705032B1
FR2705032B1 FR9305623A FR9305623A FR2705032B1 FR 2705032 B1 FR2705032 B1 FR 2705032B1 FR 9305623 A FR9305623 A FR 9305623A FR 9305623 A FR9305623 A FR 9305623A FR 2705032 B1 FR2705032 B1 FR 2705032B1
Authority
FR
France
Prior art keywords
immunoglobulin
therapy
composition
combination
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9305623A
Other languages
French (fr)
Other versions
FR2705032A1 (en
Inventor
Binder Patrice
Ramisse Francoise
Alonso Jean-Michel
Szatanik Marek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Direction General pour lArmement DGA
Original Assignee
Direction General pour lArmement DGA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Direction General pour lArmement DGA filed Critical Direction General pour lArmement DGA
Priority to FR9305623A priority Critical patent/FR2705032B1/en
Publication of FR2705032A1 publication Critical patent/FR2705032A1/en
Application granted granted Critical
Publication of FR2705032B1 publication Critical patent/FR2705032B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9305623A 1993-05-11 1993-05-11 Composition comprising in combination an immunoglobulin and an antigen usable in therapy. Expired - Fee Related FR2705032B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9305623A FR2705032B1 (en) 1993-05-11 1993-05-11 Composition comprising in combination an immunoglobulin and an antigen usable in therapy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305623A FR2705032B1 (en) 1993-05-11 1993-05-11 Composition comprising in combination an immunoglobulin and an antigen usable in therapy.

Publications (2)

Publication Number Publication Date
FR2705032A1 FR2705032A1 (en) 1994-11-18
FR2705032B1 true FR2705032B1 (en) 1995-07-07

Family

ID=9446988

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9305623A Expired - Fee Related FR2705032B1 (en) 1993-05-11 1993-05-11 Composition comprising in combination an immunoglobulin and an antigen usable in therapy.

Country Status (1)

Country Link
FR (1) FR2705032B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1470160A2 (en) * 2001-12-05 2004-10-27 Cangene Corporation Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE395034C (en) * 1919-10-05 1924-05-12 Celluloidfabrik Deutsche Process for obtaining tuberculosis immune milk containing both antibodies and antigen
FR998M (en) * 1960-12-12 1961-12-18
US3891751A (en) * 1968-05-28 1975-06-24 Merieux Inst Vaccines and processes for their preparation
FR2669538B1 (en) * 1990-11-28 1995-03-03 Fondation Nale Transfusion San USE OF LOCALLY ADMINISTERED IMMUNOGLOBULINS IN THE TREATMENT OF EPITHELIAL INFECTIONS.

Also Published As

Publication number Publication date
FR2705032A1 (en) 1994-11-18

Similar Documents

Publication Publication Date Title
DK488882A (en) IODOTHYRONIN IMMUNOGEN CONJUGATE, ANTIBODY AGAINST CONJUGATE AND IODOTHYRONIN DERIVATE
DE69110914D1 (en) Gasoline composition.
NO913542D0 (en) AZACYCLIC RELATIONS.
DE69114579D1 (en) Sealing with soft and hard sealing layers.
FR2694767B1 (en) Anti-IL6R monoclonal antibodies, and their applications.
ITRM950375A0 (en) FLOWED BITUMEN AND BITUMEN EMULSION.
DE68908422D1 (en) INCREASED COHESION IN DEVELOPED IMAGES.
MX9102569A (en) IMPROVEMENTS IN TORNAMESA.
DE3889062D1 (en) Monoclonal antibody against human BCDF.
DE69104845D1 (en) HOT DIFFUSION WELDING.
MX9201643A (en) AGENTS AGAINST TUMORS AND ANTI-PSORIASICS.
TR199600371A2 (en) Organosilan compounds blends and their use.
ITRM910151A1 (en) IMPROVEMENT IN CONTAINERS, CONTAINERS AND SIMILAR SELF-LIFTING AND MANUALLY MOBILE.
DE59305093D1 (en) HEAT STORAGE, IN PARTICULAR LATENT HEAT STORAGE
DE69101966D1 (en) Gasoline composition.
TR28651A (en) Glass composition and use.
FR2705032B1 (en) Composition comprising in combination an immunoglobulin and an antigen usable in therapy.
MX9205556A (en) IMPROVEMENTS IN NOVELTY COMPOSITIONS INCLUDING PENTAFLUOROETHANE AND MONOCLORODIFLUOROMETHANE.
MX9202642A (en) MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA.
DE68912772D1 (en) MONOCLONAL ANTIBODY AGAINST ENTERO VIRUSES.
ITMO910033A1 (en) HARDENING OVEN, IN PARTICULAR FOR GLASS AND SIMILAR SHEETS.
DE69427850D1 (en) MONOCLONAL ANTIBODY AGAINST MUCOGLYCOPROTEIN
FR2711662B1 (en) Biphasic organopolysiloxane composition usable in cosmetics.
ES1023430Y (en) CHAIR FOR PIANISTS AND THE LIKE.
NO950025L (en) Hexadate ligands, usable in radiographic imaging agents

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070131